Exploring modified chitosan-based gene delivery technologies for therapeutic advancements

Area of Science:

• Biomaterials Science
• Gene Therapy
• Nanotechnology

Background:

• Viral vectors face challenges in gene therapy due to immunogenicity and toxicity.
• Non-viral vectors, such as cationic polysaccharides, are being explored as safer alternatives.
• Chitosan, a cationic polysaccharide, interacts favorably with nucleic acids and cell membranes for gene delivery.

Purpose of the Study:

• To explore the potential of modified chitosan as an effective non-viral gene delivery vector.
• To address the limitations of native chitosan, including targetability, solubility, and buffering capacity.
• To investigate the role of the 'proton sponge effect' in endosomal escape for enhanced gene delivery.

Main Methods:

• Modification of chitosan to improve its properties for gene delivery.
• Evaluation of chitosan's interaction with nucleic acids and cell membranes.
• Assessment of the 'proton sponge effect' and its impact on endosomal pH buffering.
• Analysis of chitosan's potential for cellular uptake and gene transfection.

Main Results:

• Modified chitosan demonstrates improved targetability, solubility, and buffering capacity compared to native chitosan.
• The 'proton sponge effect' in modified chitosan facilitates endosomal escape by accumulating protons and chloride ions.
• Chitosan-based vectors show effective cellular uptake and nucleic acid delivery.

Conclusions:

• Modified chitosan presents a viable non-viral strategy for gene delivery, mitigating issues associated with viral vectors.
• Further research on high-purity chitosan is crucial to minimize toxicity and immunogenicity.
• Continued exploration of chitosan-based genetic drugs is essential for future FDA-approved formulations.